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Development of the  
International Stem Cell Registry: 
Progress and Challenges 
 
Stem cells provide novel tools for studying 
development and disease.   
Pluripotent stem cells also offer options for the 
treatment of acquired and inherited diseases that 
resist traditional strategies for drug design and 
discovery.  
Importance of Stem Cells 
 
Biology 
 Characteristics 
 Differentiation 
 
Technology 
 New methods for deriving pluripotent cells such as iPS cells 
 New techniques for growth and differentiation 
 
Applications 
 Cell replacement therapy 
 Drug screening 
 Disease models 
Stem Cells: an evolving field 
Embryonic Stem Cells 
Derivation 
 Isolated from early stage embryos 
 
Characteristics 
 Competent to form ALL specialized cells, tissues, and organs of 
the adult organism (pluripotent) 
 Indefinite life span in culture 
 
Limitations 
 Derivation normally results in embryo destruction 
 Prior to March 9, 2009, only a limited number of lines were 
available for federally funded research 
 Risk of tumors (teratomas) from transplanting undifferentiated 
cells  
Embryonic Stem Cells  
Reprogrammed cells - Induced Pluripotent Stem (iPS) cells 
Derivation 
 Isolate adult somatic cells (e.g. skin fibroblasts) 
 Viral introduction of genes expressing factors that control 
very early development 
 
Characteristics 
 Re-establish pluripotency, and indefinite lifetime in culture. 
 Cells can be developed that are matched to patients. 
 
Limitations 
 Must establish functional equivalency of IPS and human  
embryonic stem cells. 
 Viruses used in derivation may promote tumorigenesis. 
Reprogrammed cells - Induced Pluripotent Stem (iPS) cells 
 
There are hundreds of hES  and iPS cell lines worldwide, most of 
which are not published. 
 
Different states and funding agencies have different guidelines 
regarding hES cell line derivation (provenance), which has 
created a regulatory maze. 
  
Published research is not searchable by cell line. 
 
Scientists need up to date information for experimental design, 
grant applications and keeping current with the field. 
The need for a comprehensive registry 
A publicly accessible, searchable, comprehensive and 
continuously updated database that includes published and 
validated unpublished information on all pluripotent stem cell 
lines. 
Dedicated to acquiring, configuring and disseminating, 
information between providers, researchers and the broader 
scientific community. 
Includes cell lines developed by the international research 
community. (e.g., United States, Canada, Europe, Japan, 
Singapore, Australia, China) 
International Stem Cell Registry 
Developer  
Provider(s)  
Provenance  
 
Derivation 
Characterization 
Marker expression testing 
HLA and genotyping 
Literature references 
 
Registry information 
Practical 
Information 
 
 
 
 
 
Scientific 
Information 
International Stem Cell Registry 
Published literature (derivation, characterization, uses) 
 
Contact with cell line developers (unpublished data) 
 
Websites posting independently derived characterization 
information (ISCI Stem Cell Forum) 
 
Information derived by stem cell banks (QC data, etc.) 
 
Data Collection 
Data Collection - Publications 
Tools: 
PubMed - only allows search of titles, abstracts an keywords 
Crossref - Not all journals represented, difficult to sort by 
publication date 
Publication websites  
Many lines are unpublished, making identification, data 
gathering and validation difficult. 
Investigators are often unwilling to post unpublished data 
Privacy issues impede obtaining provenance information. 
Conflicting information from different sources (lack of 
standards) 
Data presentation (creating a user-friendly display of complex 
information) 
Accelerating pace of research (maintaining up to date 
information) 
Challenges 
International Stem Cell Registry         www.umassmed.edu/iscr 
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